Glaxosmithkline Pharmaceuticals2945.20
+7.70 (+0.26%)

Glaxosmithkline Pharmaceuticals Share Price

2945.20+7.70 (+0.26%)
+6.06% past 1 Year

GlaxoSmithKline (GSK) Pharmaceuticals, a subsidiary of UK-based GSK plc, is a leading global biopharma company bringing together science, technology and talent to deliver impact and get ahead of disease together

Corporate filings & documents

Announcements

As per attachment
2 days ago
As per attachment
2 days ago
As per attachment
3 days ago
As per attachment
3 days ago
As per attachment
1 week ago
As per attachment
1 week ago
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 26 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
1 week ago
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 26 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
1 week ago
As per attachment
2 weeks ago
As per attachment
2 weeks ago
As per attachment
2 weeks ago
As per attachment
2 weeks ago
As per attachment
3 weeks ago
As per attachment
3 weeks ago
Transcript
4 weeks ago
Transcript
4 weeks ago
IT Refund of Rs 52 crores
4 weeks ago
IT Refund of Rs 52 crores
4 weeks ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
Reappointment of Managing Director
1 month ago
Reappointment of Managing Director
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
Presentation
1 month ago
Presentation
1 month ago
Outcome of meeting
1 month ago
Outcome of meeting
1 month ago
Outcome of Meeting
1 month ago
Outcome of Meeting
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026.
1 month ago
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026.
1 month ago
As per attachment
1 month ago
As per attachment
1 month ago
As per attachment
2 months ago
As per attachment
2 months ago
As per attachment
2 months ago
As per attachment
2 months ago
As per attachment
2 months ago
As per attachment
2 months ago

Concalls & investor presentations

Nov 2025
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
Feb 2024
ConcallPresentation
Jul 2022
May 2021

Corporate Actions

Date
Type
Details
2026-05-29
Dividend
57.0
2025-05-30
Dividend
42.0
2024-11-07
Dividend
12.0
2024-05-31
Dividend
32.0
2023-06-30
Dividend
32.0
2022-07-07
Dividend
90.0
2021-07-19
Dividend
30.0
2020-07-17
Dividend
40.0
2019-07-11
Dividend
20.0
2018-09-11
Bonus
1:1
2018-07-13
Dividend
35.0
2017-07-14
Dividend
30.0
2016-07-15
Dividend
50.0
2015-07-23
Dividend
112.0
2014-04-03
Dividend
50.0
2013-04-04
Dividend
50.0
2012-03-29
Dividend
45.0
2011-03-14
Dividend
40.0

Company details

Registered office

252, Gsk House Dr. Annie Besant Road Worli Mumbai Maharashtra PIN: 400030 Tel No: 022-24959595 Fax No: 022-24959494 Email: [email protected] / [email protected] Internet: www.gsk-india.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

R S Karnad, Chairperson

Bhushan Akshikar, Managing Director

Manu Anand, Non Executive Independent Director

Ronojit Biswas, Whole Time Director & Chief Financial Officer

S Maheshwari, Non Executive Independent Director

P R Somasundaram, Non Executive Independent Director

Anup Wadhawan, Non Executive Independent Director

S Williams, Non Executive Director

Ajay Nadkarni, Company Secretary & Compliance Officer, Vice President – Administration, Real Estate

Karine JF Natland, Non-Execuive Director

Details

BSE 500660

NSE GLAXO

ISIN INE159A01016

Glaxosmithkline Pharmaceuticals Ltd Share Price Today

The Glaxosmithkline Pharmaceuticals Ltd share price today is ₹2,940.00. During the trading session, the Glaxosmithkline Pharmaceuticals Ltd share price opened at ₹2,962.40 and recorded an intraday high of ₹2,965.50 and a low of ₹2,931.30. Last closing price was ₹2,949.90. Over the past 52 weeks, the Glaxosmithkline Pharmaceuticals Ltd share price has ranged between ₹2,088.10 and ₹3,120.70. The current Glaxosmithkline Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.